Defunct Company
Total Trials
56
As Lead Sponsor
11
As Collaborator
45
Total Enrollment
55,275
NCT00010153
ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer
Phase: Phase 3
Role: Collaborator
Start: Nov 30, 2000
Completion: Not specified
NCT00045032
Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer
Start: Nov 30, 2001
Completion: Jun 30, 2015
NCT00066807
Premenopausal Endocrine Responsive Chemotherapy Trial
Start: Aug 31, 2003
Completion: Dec 31, 2006
NCT00066703
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
Start: Nov 3, 2003
Completion: Oct 23, 2024
NCT00066690
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
Start: Dec 17, 2003
Completion: Nov 6, 2024
NCT00135889
Continuous Femoral Nerve Block Following Total Knee Replacement
Phase: N/A
Start: Jan 31, 2005
Completion: Jul 31, 2008
NCT00433589
Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes
Start: Feb 28, 2007
Completion: Mar 31, 2020
NCT00490139
ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
Start: May 16, 2007
Completion: Jul 1, 2021
NCT00470236
Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast
Start: Jun 30, 2007
Completion: Jun 30, 2024
NCT00553410
Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer
Start: Aug 31, 2007
Completion: May 15, 2019
NCT00553358
Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study
Start: Jan 5, 2008
Completion: Dec 23, 2019
NCT00780273
Success Rate of Immediately Loaded Implants With Platform Switched Design Placed in Anterior Part of Mandible and Restored With Fixed Prostheses
Phase: Phase 4
Role: Lead Sponsor
Start: Sep 30, 2008
Completion: Apr 30, 2012
NCT00963417
Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02
Start: Aug 3, 2009
NCT01591616
Pediatric Study to Access Pharmacokinetics and Safety of Oraqix Gel
Start: Apr 30, 2010
NCT01101425
Male Breast Cancer: Understanding the Biology for Improved Patient Care
Start: Dec 31, 2010
Completion: Mar 31, 2024
NCT01610167
NUPRO(r) Sensodyne Prophylaxis Paste With NovaMin(r)Sensitivity Relief Study
Start: Sep 30, 2011
Completion: Dec 31, 2011
NCT01496846
Efficacy Study of Articaine Versus Lidocaine as Supplemental Infiltration in Inflamed Molars
Completion: Feb 29, 2016
NCT01358877
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
Start: Nov 8, 2011
Completion: Nov 28, 2024
NCT01523613
High-strength Glass-ionomer Dental Restorations
Start: Nov 30, 2011
Completion: Oct 31, 2014
NCT01669785
NUPRO Sensodyne Prophylaxis Paste With NovaMin Sensitivity Relief Study
Start: Mar 31, 2012
Completion: May 31, 2012
NCT01759537
Study to Evaluate Bone and Gum Dimension Changes Around Dental Implants Placed in Different Positions in Bone.
Start: Apr 30, 2012
Completion: Apr 30, 2019
NCT02071953
Comparative Study of Experimental Dental Adhesive With and Without Phosphoric Acid Pretreatment
Completion: Sep 30, 2014
NCT01746225
Schedules of Nab-Paclitaxel in Metastatic Breast Cancer
Phase: Phase 2
Start: Apr 30, 2013
Completion: Mar 16, 2023
NCT02094742
BIG Molecular Screening Feasibility Study
Start: May 31, 2013
Completion: Aug 31, 2014
NCT01816594
NeoPHOEBE: Neoadjuvant Trastuzumab + BKM120 in Combination With Weekly Paclitaxel in HER2-positive Primary Breast Cancer
Start: Sep 3, 2013
Completion: Feb 18, 2015
NCT01864746
A Study of Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and Surgery
Start: Oct 30, 2013
Completion: Dec 21, 2020
NCT02105896
Clinical Evaluation of Total-Etch and Self-Etch Dental Adhesives - 6 Year Recall
Start: Nov 30, 2013
NCT02053636
A Phase II Trial Testing Oral Administration of Lucitanib in Patients With Fibroblast Growth Factor Receptor (FGFR)1-amplified or Non-amplified Estrogen Receptor Positive Metastatic Breast Cancer
Start: Dec 31, 2013
Completion: Apr 4, 2017
NCT01905592
A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients
Start: Feb 25, 2014
Completion: Oct 26, 2021
NCT02032823
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Start: Apr 22, 2014
Completion: May 28, 2029
NCT02102165
AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer.
Start: Apr 30, 2014
Completion: Mar 31, 2031
NCT02273973
A Study of Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI)
Start: Nov 12, 2014
Completion: Mar 13, 2017
NCT02308085
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Start: Dec 4, 2014
Completion: Dec 31, 2028
NCT02129556
Anti-PD-1 Monoclonal Antibody in Advanced, Trastuzumab-resistant, HER2-positive Breast Cancer
Phase: Phase 1/2
Start: Dec 31, 2014
Completion: Aug 4, 2017
NCT02513394
PALbociclib CoLlaborative Adjuvant Study
Start: Aug 31, 2015
NCT02991573
Clinical Study Class II on Ceram.x Universal and Prime&Bond
Start: Nov 30, 2015
Completion: Mar 31, 2022
NCT02596048
A Multicenter Study of Iomeron®-400 Used With Multi-detector Computed Tomography Angiography (MDCTA)
Start: Dec 31, 2015
Completion: Apr 30, 2017
NCT02685995
VectorFlow Tunneled Dialysis Catheter (TDC) Versus Palindrome TDC
Completion: Jul 31, 2020
NCT02532543
Comparative Volumetric Assessment of Alveolar Ridge Preservation Utilizing Different Bone Grafting Materials
Start: Apr 30, 2016
Completion: Feb 12, 2018
NCT02536742
Palbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast Cancer
Start: Aug 30, 2016
Completion: Dec 22, 2022
NCT02979808
An Open, Qualitative, Prospective, Multicenter Trial of a Novel Transanal Irrigation System in Spinal Cord Injured Patients.
Start: Oct 31, 2016
Completion: Dec 31, 2019
NCT04518020
Single Crown Supported by Short Implant Versus Standard Implant in Conjunction With Maxillary Sinus Floor Augmentation.
Start: Nov 16, 2016
Completion: Jul 1, 2025
NCT03019302
Arrow Chloragard Peripherally-Inserted Central Catheters (PICC) Study
Start: Dec 31, 2016
Completion: Sep 30, 2017
NCT02997995
Durvalumab and Endocrine Therapy in ER+/Her2- Breast Cancer After CD8+ Infiltration Effective Immune-Attractant Exposure
Start: Feb 15, 2017
Completion: Aug 28, 2020
NCT02889874
EXamining PErsonalised Radiation Therapy for Low-risk Early Breast Cancer
Start: Aug 21, 2017
Completion: Apr 30, 2028
NCT03495700
Lateral Sinus Floor Elevation in Implant Therapy.
Start: Mar 19, 2018
Completion: Jun 30, 2022
NCT03496038
Transcrestal Lateral Sinus Floor Elevation in Implant Therapy
NCT03498716
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
Start: Aug 2, 2018
Completion: Aug 14, 2023
NCT03684941
Evaluation of a New Catheter Coating Process for Urinary Catheters Used for Intermittent Catheterization.
Start: Aug 29, 2018
Completion: Nov 19, 2018
NCT03997604
A Descriptive, Prospective Clinical Study to Evaluate Full Dentures Fabricated by Additive Manufacturing
Start: May 29, 2019
Completion: Oct 29, 2022
NCT03609047
Adjuvant Palbociclib in Elderly Patients With Breast Cancer
Start: Jun 14, 2019
Completion: Sep 30, 2032
NCT04023006
An Observational Clinical Case Series Study to Assess Fit and Quality of Full Dentures Fabricated by AM
Start: Aug 1, 2019
Completion: Apr 1, 2020
NCT05063786
Trastuzumab + Alpelisib +/- Fulvestrant vs Trastuzumab + CT in Patients With PIK3CA Mutated Previously Treated HER2+ Advanced BrEasT Cancer (ALPHABET)
Start: Sep 14, 2021
Completion: Jun 30, 2026
NCT04675827
De-escalation Adjuvant Chemo in HER2+/ER-/node-neg Early BC Patients Who Achieved PCR After Neoadjuvant Chemo & Dual HER2 Blockade
Start: Jan 17, 2022
Completion: Nov 26, 2024
NCT05128773
Study of Amcenestrant (SAR439859) Versus Tamoxifen for Patients With Hormone Receptor-positive (HR+) Early Breast Cancer, Who Have Discontinued Adjuvant Aromatase Inhibitor Therapy Due to Treatment-related Toxicity
Start: Feb 17, 2022
Completion: Oct 13, 2022
NCT05512364
Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
Start: Dec 15, 2023
Completion: Nov 1, 2035